Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikhil Patkar

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Blood Cancer Journal|November 1, 2025
Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in IndiaSachin Punatar, Nishant Jindal, Anant Gokarn, et al.
Indian Journal of Pathology & Microbiology|June 21, 2017
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemiaNikhil Patkar, P G Subramanian, Prashant Tembhare, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 28, 2023
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with VenetoclaxTarang Gaur, Ramulu Poddutoori, Leena Khare, et al.
Blood Advances|February 26, 2021
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocolAkhil Rajendra, Hasmukh Jain, V N Avinash Bonda, et al.
Annals of Hematology|July 21, 2023
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, IndiaNirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V Velagala, et al.
British Journal of Haematology|December 15, 2023
Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey, et al.
Cancer Medicine|July 16, 2025
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple MyelomaSumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, et al.
Blood Cells, Molecules & Diseases|July 22, 2020
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALLDhanlaxmi Shetty, Pratibha Kadam Amare, Purvi Mohanty, et al.
Cytometry. Part B, Clinical Cytometry|February 25, 2022
Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B-cell acute lymphoblastic leukemia using multicolor flow cytometryAnumeha Chaturvedi, Dhanalaxmi Shetty, Sitaram Gundu Ghogale, et al.
Frontiers in Oncology|March 18, 2022
Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in IndiaPrashant R Tembhare, Gaurav Chatterjee, Anumeha Chaturvedi, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Blood Cancer Journal|November 1, 2025
Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in IndiaSachin Punatar, Nishant Jindal, Anant Gokarn, et al.
Indian Journal of Pathology & Microbiology|June 21, 2017
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemiaNikhil Patkar, P G Subramanian, Prashant Tembhare, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 28, 2023
Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with VenetoclaxTarang Gaur, Ramulu Poddutoori, Leena Khare, et al.
Blood Advances|February 26, 2021
Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocolAkhil Rajendra, Hasmukh Jain, V N Avinash Bonda, et al.
Annals of Hematology|July 21, 2023
Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) - experience from Tata Memorial Hospital, IndiaNirmalya Roy Moulik, Swaminathan Keerthivasagam, Swetha V Velagala, et al.
British Journal of Haematology|December 15, 2023
Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey, et al.
Cancer Medicine|July 16, 2025
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple MyelomaSumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, et al.
Blood Cells, Molecules & Diseases|July 22, 2020
Investigating the clinical, hematological and cytogenetic profile of endoreduplicated hypodiploids in BCP-ALLDhanlaxmi Shetty, Pratibha Kadam Amare, Purvi Mohanty, et al.
Cytometry. Part B, Clinical Cytometry|February 25, 2022
Detecting hypodiploidy with endoreduplication and masked hypodiploidy in B-cell acute lymphoblastic leukemia using multicolor flow cytometryAnumeha Chaturvedi, Dhanalaxmi Shetty, Sitaram Gundu Ghogale, et al.
Frontiers in Oncology|March 18, 2022
Critical Role of Flow Cytometric Immunophenotyping in the Diagnosis, Subtyping, and Staging of T-Cell/NK-Cell Non-Hodgkin's Lymphoma in Real-World Practice: A Study of 232 Cases From a Tertiary Cancer Center in IndiaPrashant R Tembhare, Gaurav Chatterjee, Anumeha Chaturvedi, et al.
Pageof 9